Patricia Winokur
Infectious Disease · Iowa City, IANPI 1568444883
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,800 of the $2,820 with a category attached, or 99.3%. Every reported general payment came from a single manufacturer, Pfizer. Among infectious disease clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3 payments — averaging $940.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
Across 267 payments — averaging $18,014 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4.8M
- Sanofi Pasteur Inc.$9K
What the payments were for
- Speaking & faculty fees$2,80099%
- Gifts$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $2,820 |
How this compares
$2,820 in reported general payments places this provider in the 90th percentile of 58 infectious disease providers in Iowa.
Other infectious disease in Iowa City
- Michael OhlIowa City$9K
- Upinder SinghIowa City$8K
- Karen BrustIowa City$4K
- Yacoub SallamIowa City$631
- Lemuel Benedict NonIowa City$619
- David KusnerIowa City$207
- Eric DahlquistIowa City$125
- Jacob HodgesIowa City$84
- Dilek InceIowa City$36
- Quanhathai KaewpoowatIowa City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.